Méndez-Sánchez N, Chávez-Tapia NC, Uribe M

Language: Spanish
References: 60
Page: 59-66
PDF size: 561.83 Kb.

ABSTRACT

Gallbladder disease is a very common diagnosis and implies great economic cost. Gallbladder disease is a multifactorial process involved with host and environmental factors. Obesity is considered one of the most important risk factor associated with gallstone disease and is very important mainly due its increased prevalence worldwide. Several changes in cholesterol metabolism tend to increase gallbladder cholesterol secretion in conjunction with motility disturbances, which aids in gallstone growth. In this work, epidemiologic and pathophysiologic factors related with obesity and gallstone disease are discussed.

REFERENCES

1. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002;122(5):1500-11.

2. Russo MW, Wei JT, Thiny MT, et al. Digestive and liver diseases statistics, 2004. Gastroenterology. 2004;126(5):1448-53.

3. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-9.

4. Puschel K, Sullivan S, Montero J, Thompson B, Díaz A. [Cost-effectiveness analysis of a preventive program for gallbladder disease in Chile]. Rev Med Chil 2002;130(4):447-59 (en espańol).

5. González-Villalpando C, Rivera-Martínez D, Arredondo-Pérez B, et al. High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. Arch Med Res 1997;28(4):543-7.

6. Méndez-Sánchez N, Chávez-Tapia NC, Uribe M. The role of dietary fats in the pathogenesis of gallstones. Front Biosci 2003;8:e420-e427.

7. Misciagna G, Centonze S, Leoci C, et al. Diet, physical activity, and gallstones- a population-based, case-control study in southern Italy. Am J Clin Nutr 1999;69(1):120-6.

8. Rudnicki M, Jorgensen T, Jensen KH, Thode J. Calcium, magnesium, and free fatty acids in the formation of gallstones: a nested case-control study. Am J Epidemiol 1993;13 (4):404-8.

9. Jankowska EA, Rogucka E, Medras M, Welon Z. Relationships between age-related changes of sex steroids, obesity and body fat distribution among healthy Polish males. Med Sci Monit 2000;6(6):1159-64.

10. Valdivieso V, Palma R, Wunkhaus R, Antezana C, Severin C, Contreras A. Effect of aging on biliary lipid composition and bile acid metabolism in normal Chilean women. Gastroenterology 1978;74(5 Pt 1):871-4.

11. Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985;313(5):277-82.

12. Strasberg SM. The pathogenesis of cholesterol gallstones: a review. J Gastrointest Surg 1998;2(2):109-25.

13. Sichieri R, Everhart JE, Roth H. A prospective study of hospitalization with gallstone disease among women: role of dietary factors, fasting period, and dieting. Am J Public Health 1991;81(7):880-4.

14. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992;55(3):652-8.

15. Thijs C, Knipschild P, Leffers P. Is gallstone disease caused by obesity or by dieting? Am J Epidemiol 1992;135(3):274-80.

16. Bennion LJ, Grundy SM. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975;56(4):996-1011.

17. Stahlberg D, Rudling M, Angelin B, et al. Hepatic cholesterol metabolism in human obesity. Hepatology 1997;25(6):1447-50.

18. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289(2):187-93.

19. Nakeeb A, Comuzzie AG, Martin L, et al. Gallstones: genetics versus environment. Ann Surg 2002;235(6):842-9.

20. Chávez-Tapia NC, Vidal-Tamayo RF, Lizardi-Cervera J. Factores de riesgo en diabetes mellitus tipo 2. Med Int Mex 2003;19(5):301-10.

21. Wauters M, Mertens I, Chagnon M, et al. Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord 2001;25(5):714-20.

22. Chávez-Tapia NC, Sánchez-Lara K, Motola-Kuba D, et al. Obesidad y resistencia a la insulina en sujetos con litiasis vesicular. Med Int Mex 2003;19(Supl 1):S33.

23. Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 1999;130(6):471-7.

24. Méndez-Sánchez N, Chávez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome is strongly associated with gallstone disease. Liver Int 2003;24:23.

25. Lillioja S, Foley J, Bogardus C, Mott D, Howard BV. Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons. Metabolism 1986;35(6):505-14.

26. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (second of two parts). N Engl J Med 1978;299(22):1221-7.

27. Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man (first of two parts). N Engl J Med 1978;299(21):1161-7.

28. Reihner E, Bjorkhem I, Angelin B, Ewerth S, Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. Gastroenterology 1989;97(6):1498-505.

29. Kahn BB. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 1998;92(5):593-6.

30. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334(5):292-5.

31. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1(11):1155-61.

32. Scragg RKR, Calvert GD, Oliver JR. Plasma lipids and insulin in gallstone disease: a case-control study. Br Med J 1984;289:521-5.

33. Laakso M, Suhonen M, Julkunen R, Pyorala K. Plasma insulin, serum lipids and lipoproteins in gall stone disease in noninsulin dependent diabetic subjects: a case control study. Gut 1990;31(3):344-7.

34. Haffner SM, Diehl AK, Mitchell BD, Stern MP, Hazuda HP. Increased prevalence of clinical gallbladder disease in subjects with non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990;132(2):327-35.

35. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000;31(2):299-303.

36. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology 1988;8(4):907-13.

37. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990;131(5):836 44.

38. Kono S, Shinchi K, Ikeda N, Yanai F, Imanishi K. Prevalence of gallstone disease in relation to smoking, alcohol use, obesity, and glucose tolerance: a study of self defense officials in Japan. Am J Epidemiol 1992;136(7):787-94.

39. Kato I, Nomura A, Stemmermann GN, Chyou PH. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors. Dig Dis Sci 1992;37(5):784-90.

40. Torgerson JS, Lindroos AK, Naslund I, Peltonen M. Gallstones, gallbladder disease, and pancreatitis: crosssectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol 2003;98(5):1032-41.

41. Leitzmann MF, Giovannucci EL, Rimm EB, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med. 1998;128(6):417-25.

42. Méndez-Sánchez N, Jessurun J, Ponciano-Rodríguez G, Alonso-de-Ruiz P, Uribe M, Hernández-Avila M. Prevalence of gallstone disease in Mexico. A necropsy study. Dig Dis Sci 1993;38(4):680-3.

43. Carey MC. Homing-in on the origin of biliary steroids. Gut 1997;41:721-2.

44. Watson KE, Horowitz BN, Matson G. Lipid abnormalities in insulin resistant states. Rev Cardiovasc Med 2003;4(4):228-36.

45. Busch N, Matern S. Current concepts in cholesterol gallstone pathogenesis. Eur J Clin Invest 1991;21(5):453-60.

46. Hay DW, Carey MC. Pathophysiology and pathogenesis of cholesterol gallstone formation. SeminLiverDis1990;10(3):159-70.

47. Paumgartner G, Sauerbruch T. Gallstones: pathogenesis. Lancet 1991;338(8775):1117-21.

48. Trotman BW. Pigment gallstone disease. Gastroenterol Clin North Am 1991;20(1):111-26.

49. Tran KQ, Goldblatt MI, Swartz-Basile DA, Svatek C, Nakeeb A, Pitt HA. Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity. J Gastrointest Surg 2003;7(7):857-62, discussion 863.

50. Yu P, Chen Q, Harnett KM, Amaral J, Biancani P, Behar J. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. Am J Physiol 1995;269(5 Pt 1):G659-G665.

51. Vezina WC, Paradis RL, Grace DM, et al. Increased volume and decreased emptying of the gallbladder in large (morbidly obese, tall normal, and muscular normal) people. Gastroenterology 1990;98(4):1000-7.

52. Hayashi H, Sato Y, Kanai S, Ichikawa M, Funakoshi A, Miyasaka K. Increased lymphatic lipid transport in genetically diabetic obese rats. Am J Physiol Gastrointest Liver Physiol 2002;282(1):G69-G76.

53. Farkkila M, Miettinen TA. Lipid metabolism in bile acid malabsorption. Ann Med 1990;22(1):5-13.

54. Lewis SJ, Heaton KW. The metabolic consequences of slow colonic transit. Am J Gastroenterol 1999;94(8):2010-6.

55. Dowling RH, Veysey MJ, Pereira SP, et al. Role of intestinal transit in the pathogenesis of gallbladder stones. Can J Gastroenterol 1997;11(1):57-64.

56. Hukshorn CJ, Saris WH, Westerterp-Plantenga MS, Farid AR, Smith FJ, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab 2000;85(11):4003-9.

57. Lee DW, Leinung MC, Rozhavskaya-Arena M, Grasso P. Leptin and the treatment of obesity: its current status. Eur J Pharmacol 2002;440(2-3):129-39.

58. Tran KQ, Graewin SJ, Swartz-Basile DA, Nakeeb A, Svatek CL, Pitt HA. Leptin resistant obese mice have paradoxically low biliary cholesterol saturation. Surgery 2003;134(2):372-7.

59. Graewin SJ, Lee K, Tran KQ, et al. Leptin-resistant obese mice do not form biliary crystals on a high cholesterol diet. J Surg Res 2003;114(2):291.

60. Nishina PM, Lowe S, Wang J, Paigen B. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994;43(5):549-53.